NEW YORK ( TheStreet) -- Shares of Amyris (Nasdaq: AMRS) were gapping down Wednesday morning with an open price 15.8% lower than Tuesday's closing price. The stock closed at $2.53 Tuesday and opened today's trading at $2.13. The average volume for Amyris has been 523,900 shares per day over the past 30 days. Amyris has a market cap of $139.1 million and is part of the health care sector and drugs industry. Shares are down 78.1% year to date as of the close of trading on Tuesday. Amyris, Inc., an integrated renewable products company, provides alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. TheStreet Ratings rates Amyris as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full Amyris Ratings Report. Get more investment ideas from our investment research center.
More from Markets
Should We Buy the Dip or Prepare for More Downside?
Here are some tools to determine whether we can expect big market shifts.
Equifax to Pay Up to $700 Million in Data Breach Settlement
Equifax agrees to pay up to $700 million to settle privacy claims stemming from a 2017 data breach.
Equifax, Whirlpool, 'The Lion King,' China's STAR Market: 5 Things You Must Know
U.S. stock futures rise as earnings season ramps up in a week heavy with reports from U.S. tech giants; Earnings reports are expected Monday from Whirlpool and Halliburton; Equifax agrees to pay up to $700 million to settle privacy claims stemming from a 2017 data breach; Walt Disney's 'The Lion King' grosses $185 million over its opening weekend in North America.
Jim Cramer Reveals His 3 Keys to Surviving Earnings Season
Jim Cramer has some advice for investors who are baffled by this market and how to react to earnings from some of his favorite stocks .